A plausible explanation for this phenomenon is that early-stage AML cells depend on Bcl-XL for survival, whereas late-stage AML cells may rely on other Bcl-2 family members, such as Bcl-2 or MCL-1. This evidence concerns the gene BCL2 and acute myeloid leukemia.